Accelerating Echo® MS system optimization with LeadScape®

Jun 17, 2026 | Blogs, Echo® MS+ system, Pharma, SCIEX OS software | 0 comments

Read time: 2 minutes

In this video, Daniel Collins, PhD, from Monash University shares how they are using LeadScape Optimize on the SCIEX OS platform at the Centre for Drug Candidate Optimisation, in Melbourne, Australia.

For more than 20 years, the CDCO has supported academic, commercial, and not‑for‑profit drug discovery programs with deep expertise in pharmaceutical lead optimization. Within the bioanalytical group, their role is to enable rapid and reliable decision‑making through quantitative analysis of candidate drugs in biological matrices.

As they have adopted acoustic ejection mass spectrometry using the Echo® MS system, the speed of sample analysis has increased dramatically. This shift has highlighted a new challenge, traditional manual MRM optimization can quickly become the bottleneck.

Daniel walks through how LeadScape Optimize helps address this issue by automating compound optimization and MRM generation directly within SCIEX OS software. This workflow reduces hands‑on analyst time, improves consistency, and enables us to keep pace with the throughput potential of Echo® MS system.

Practical examples from our Caco‑2 permeability assay, compare automated and guided optimization approaches, and highlight why this level of automation is becoming essential for modern lead optimization workflows.

Performance and benefits

Using the default settings, LeadScape Optimize performs a rapid positive and negative ion sweep before refining the optimal transitions. This process takes approximately four and a half minutes per compound, representing a modest time saving compared with guided MRM.

Where LeadScape truly excels, however, is in automation. The optimization runs without analyst intervention, freeing scientists to perform other tasks such as data review, method development on other instruments, or running parallel assays.

In direct comparisons, the MRMs generated by LeadScape were comparable to those derived from manual or guided optimization within SCIEX OS software. In our hands, the transitions were reliable, accurate, and well suited to quantitative Echo® MS system analyses.

Daniel explain how the CDCO, currently use LeadScape Optimize as a standalone MRM optimization tool for Echo® MS system‑based workflows, and it has already delivered significant benefits. As they move towards adopting the Analyse functionality more broadly, we expect these benefits to increase further.

Watch the full video here

 

 

PFAS FAQ’s: Ask our experts

As PFAS testing continues to expand, laboratories face increasing pressure to deliver reliable results at lower detection limits and faster turnaround times. While much of the conversation focuses on analytical methods and regulations, maintaining instrument performance and minimizing downtime are equally critical to success.

How LC-MS laboratories in regulated environments can build a strong foundation for reliable data, audit readiness and lifecycle control

Whether supporting pharmaceutical quality control, bioanalysis, clinical research, environmental testing, or food safety applications, regulated laboratories share a common responsibility: ensuring reliable data, maintaining audit readiness, and controlling systems throughout their lifecycle. Yet when compliance discussions arise, attention often moves quickly to audits, documentation, electronic records, and standard operating procedures. These elements are essential, but they depend on a more fundamental question: Can the analytical system consistently produce reliable results?

Future-proofing pesticide testing: Why speed is becoming a competitive advantage

Food testing laboratories face growing pressure. Pesticide panels continue to expand, regulations evolve, and customers still expect fast turnaround times at a competitive cost.

Posted by

Senior Product Manager, Echo® MS+ system Kean Woodmansey is the Senior Product Manager for the Echo® MS system at SCIEX. In this role, he is responsible for the strategic success of the Echo MS+ portfolio. Kean spent the first part of his career working in contract research organizations, doing bioanalysis, before moving into pharma market development and product management.

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network